India

In southern Chhattisgarh, where MSF runs mobile clinics, a doctor attends to a patient who arrived in a critical condition. India, October 2019. © MSF/Tadeu Andre

Despite improved access to healthcare in India, a combination of high costs, poverty, social exclusion and an over-burdened public health system prevents people from seeking medical assistance.

MSF continues to work with vulnerable communities, providing mental healthcare and treatment for infectious diseases, drug-resistant tuberculosis (DR-TB), sexual violence and malnutrition…

Read full article in International Activity Report 2019

related articles

Joan, médecin MSF, donne une consultation à Nischaya, une patiente atteinte de tuberculose ultrarésistante, dans la clinique MSF de Mumbai. Octobre 2016. © Atul Loke/Panos Pictures

India

MSF calls again on J&J to withdraw patents on life-saving tuberculosis drugs

MSF also called for a commitment from J&J to not take any legal action against any generic manufacturer that exports generic versions of bedaquiline to or from TB high-burden countries where secondary patents on the drug exist. The corporation should make this announcement public by the UN TB Summit taking place in New York this September.

Mother of six-year-old MDR TB girl child administering manipulated form of DRTB drugs

India

“Pharmaceutical corporations must open up to generic supply and lower prices”

MSF welcomes the new WHO guidance that expand use of new drugs to the youngest and most vulnerable children of all ages with drug-resistant tuberculosis, although procurement and access to the new pediatric formulations of second line drugs, including Bedaquiline and Delamanid, is urgently needed.

Le Dr Sharanya Ramakrishna, médecin MSF, prélève un échantillon par écouvillonnage dans la zone de collecte d'échantillons du centre de santé COVID-19 de l'hôpital Pandit Madan Mohan Malviya Shatabdi à Mumbai. ©Abhinav Chatterjee/MSF

India

The devastating COVID-19 second wave pushing healthcare provision to the limits

The second wave of COVID-19 is reaching extremely alarming levels in India. MSF recently scaled up its intervention in Mumbai.

Tuberculose MSF Inde

India

Tuberculosis treatment: contestation to prevent J&J from extending monopoly

The patent prevents the production of affordable generic versions.

India

Pfizer patent on pneumonia vaccine limits access for children

At today's New Delhi High Court hearing, calls on India to review its decision, which reinforces Pfizer's monopoly on pneumonia vaccine.

India

Indian Patent Office Delivers Major Blow to Affordable Pneumonia Vaccine Hopes

The granting of this patent would block other manufacturers in India from supplying this vaccine - which protects against 13 types of pneumococcal bacteria - to those who need it most.

India

India: Renewed hope with new drugs

Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for tuberculosis (TB) patients with the most extreme forms of drug resistance.